Jul 2026
Circular RNA-based therapeutic vaccine elicits potent antigen-specific antitumor immunity and remodels tumor microenvironment in lung cancer.
The findings demonstrate the immunogenicity and therapeutic potential of the NeoAna circRNA-based therapeutic vaccine, supporting its further evaluation in clinical trials.
Shao-Yi Chen, Lin Weng, Xu Liu et al.
· Cancer Letters · 1 citation